StuartCampbellRayMDFACP, FIDSA(He/Him)

HIV/AIDS Medicine, Clinical Informatics

Professor of Medicine and Oncology, Vice Chair of Medicine for Data Integrity and Analytics, Johns Hopkins University School of Medicine

Dr. Ray is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Academic physician-researcher-educator with primary interest in RNA virus evolution, basic aspects of humoral and cellular immunology, and translational implications. Longstanding interest in computational biology as well as clinical informatics, with institution-level strategic involvement. Clinical activities range from COVID-19, viral hepatitis, and HIV/AIDS to internal medicine. Educational activities include clinical instruction (Infectious Diseases fellows, internal medicine housestaff, and medical students), classroom instruction (medical students, Graduate Immunology and Pharmacology students, JHSPH graduate students, and JHU Homewood undergraduates), and ACGME accredited training programs for residents and fellows.

Elected Member The American Society for Clinical Investigation, 2009
Fellow, American College of Physicians (FACP) American College of Physicians, 2016
Fellow, Infectious Diseases Society of America (FIDSA) Infectious Diseases Society of America, 2009

PubMed

2 citations
Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance.
Clinton O Ogega, Nicole E Skinner, Marta V Schoenle, Xander E Wilcox, Nicole Frumento
Immunity. 2024-04-09
4 citations
Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection.
Nicole Frumento, Ariadne Sinnis-Bourozikas, Harry T Paul, Georgia Stavrakis, Muhammad N Zahid
Immunity. 2024-01-09
4 citations
Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model.
T Jake Liang, John L M Law, Thomas Pietschmann, Stuart C Ray, Jens Bukh
Clinical Infectious Diseases. 2023-08-14

Journal Articles

CMPK2 and BCL-G Are Associated with Type 1 Interferon–Induced HIV Restriction in Humans
Justin R. Bailey, Joel N. Blankson, Robert F. Siliciano, Stuart C. Ray, Ramy El-Diwany, Science Magazine

Books/Book Chapters

Principles and Practices of Infectious Diseases
Chapter: Hepatitis C
Page 1904 - 1927Ray SC, Thomas DLEditors: Bennett JE, Dolin R, Blaser MJ.Elsevier Saunders, PhiladelphiaEdition 8,2015
Fields Virology
Chapter: Hepatitis C
Page 795 - 824Ray SC, Bailey JR, Thomas DLEditors: Knipe DM and Howley PM.Lippincott, Williams & Wilkins, PhiladelphiaEdition 6,2013
Principles and Practices of Infectious Diseases
Chapter: Hepatitis C
Page 2157 - 2186Ray SC, Thomas DLEditors: Mandell GL, Bennett JE, Dolin R.Churchhill Livingstone, PhiladelphiaEdition 7,2009
Principles and Practices of Infectious Diseases
Chapter: Hepatitis C
Page 1736 - 1760Thomas DL, Ray SC, Lemon SMEditors: Mandell GL, Bennett JE, Dolin R.Churchhill Livingstone, PhiladelphiaEdition 6,2004
Join now to see all

Dozens Fall Ill on Hawaii Hiking Trail in ‘Concerning’ Outbreak of NorovirusSeptember 7th, 2024
Severe COVID-19 Is Associated with Accelerated Aging | Fact CheckMay 18th, 2023
Is There a Best Time of Day to Get Your COVID Shot?May 11th, 2023
Join now to see all

Committee member, National Academy of Medicine: Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2 2020 - 2020
Member, Institute of Medicine: A National Strategy for the Elimination of Hepatitis B and C 2015 - 2017